Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Egypt intl phr | Egitto | Salute | Prodotti farmaceutici | 6,66 Mrd EGP | 5,8x | 0,18 | 44,62 EGP | 0,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Tenth of Ramadan | Egitto | Salute | Prodotti farmaceutici | 5,11 Mrd EGP | 19,1x | 1,13 | 3,41 EGP | 0,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 26,7% Rialzo | Fai l’upgrade a Pro+ | |
Glaxo egypt | Egitto | Salute | Prodotti farmaceutici | 3,33 Mrd EGP | 27,4x | 0,15 | 39,85 EGP | 1,6% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Minapharm Pharmaceuticals | Egitto | Salute | Prodotti farmaceutici | 2,12 Mrd EGP | -11,2x | 0,07 | 190 EGP | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Kahira Pharmaceuticals and Chemical Industries | Egitto | Salute | Prodotti farmaceutici | 1,75 Mrd EGP | 7,1x | 0,05 | 117 EGP | 0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Alx. pharmaceu | Egitto | Salute | Prodotti farmaceutici | 1,51 Mrd EGP | 7,3x | 0,1 | 302,52 EGP | -4,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Macro Pharmaceutical | Egitto | Salute | Prodotti farmaceutici | 1,44 Mrd EGP | -3,1x | 0,01 | 2,53 EGP | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
October Pharma | Egitto | Salute | Prodotti farmaceutici | 1,31 Mrd EGP | 9,6x | 3,24 | 100,58 EGP | -7,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Arab Pharmaceuticals | Egitto | Salute | Prodotti farmaceutici | 804,06 Mln EGP | 8,3x | 0,22 | 134,02 EGP | -6,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Nile pharmaceu | Egitto | Salute | Prodotti farmaceutici | 565,38 Mln EGP | 23x | -0,3 | 55,56 EGP | -0,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sabaa Intl Pharma and Chemical Industries | Egitto | Salute | Prodotti farmaceutici | 342,50 Mln EGP | -40,6x | 0,42 | 1,37 EGP | -1,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Memphis Pharmaceuticals | Egitto | Salute | Prodotti farmaceutici | 300,94 Mln EGP | 1x | 0,01 | 52,75 EGP | 0,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |